DK3469372T3 - Fremgangsmåder til diagnose og overvågning ved hjælp af urinproteiner som markører i iga-nefropati - Google Patents

Fremgangsmåder til diagnose og overvågning ved hjælp af urinproteiner som markører i iga-nefropati Download PDF

Info

Publication number
DK3469372T3
DK3469372T3 DK17736762.0T DK17736762T DK3469372T3 DK 3469372 T3 DK3469372 T3 DK 3469372T3 DK 17736762 T DK17736762 T DK 17736762T DK 3469372 T3 DK3469372 T3 DK 3469372T3
Authority
DK
Denmark
Prior art keywords
markers
diagnosis
approaches
monitoring
iga nephropathy
Prior art date
Application number
DK17736762.0T
Other languages
English (en)
Inventor
Krzysztof Mucha
Leszek Paczek
Radoslaw Zagozdzon
Bartosz Foroncewicz
Michal Dadlez
Magdalena Bakun
Jan Piwowarski
Tomas Pilzys
Michal Marcinkowski
Damian Garbicz
Elzbieta Grzesiuk
Michal Florczak
Original Assignee
Univ Warszawski Medyczny
Inst Biochemii I Biofizyki Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Warszawski Medyczny, Inst Biochemii I Biofizyki Polskiej Akademii Nauk filed Critical Univ Warszawski Medyczny
Application granted granted Critical
Publication of DK3469372T3 publication Critical patent/DK3469372T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827Total protein determination, e.g. albumin in urine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/493Physical analysis of biological material of liquid biological material urine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • G01N33/6857Antibody fragments
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/473Recognins, e.g. malignin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/79Transferrins, e.g. lactoferrins, ovotransferrins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DK17736762.0T 2016-06-10 2017-06-12 Fremgangsmåder til diagnose og overvågning ved hjælp af urinproteiner som markører i iga-nefropati DK3469372T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL41751516 2016-06-10
PCT/IB2017/053479 WO2017212463A1 (en) 2016-06-10 2017-06-12 Methods for diagnosis, differentiation and monitoring using urine proteins as markers in iga nephropathy

Publications (1)

Publication Number Publication Date
DK3469372T3 true DK3469372T3 (da) 2023-06-06

Family

ID=59295240

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17736762.0T DK3469372T3 (da) 2016-06-10 2017-06-12 Fremgangsmåder til diagnose og overvågning ved hjælp af urinproteiner som markører i iga-nefropati

Country Status (6)

Country Link
US (1) US11029314B2 (da)
EP (1) EP3469372B1 (da)
DK (1) DK3469372T3 (da)
ES (1) ES2946541T3 (da)
PL (1) PL3469372T3 (da)
WO (1) WO2017212463A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119165152A (zh) * 2019-01-17 2024-12-20 国立大学法人冈山大学 IgA肾病发病可能性的判断方法及试剂盒
EP4097481A1 (en) 2020-01-31 2022-12-07 Warszawski Uniwersytet Medyczny Method of differentiating of a chronic kidney disease or glomerulopathy, method of monitoring a response to treatment of a chronic kidney disease or glomerulopathy in a subject and a method of treatment of a chronic kidney disease or glomerulopathy
AU2020426204A1 (en) 2020-01-31 2022-12-22 Instytut Biochemii I Biofizyki Pan Method of screening for a chronic kidney disease or glomerulopathy, method of monitoring a response to treatment of a chronic kidney disease or glomerulopathy in a subject and a method of treatment of a chronic kidney disease or glomerulopathy

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003588A1 (en) 2001-06-28 2003-01-02 Comper Wayne D. Method for kidney disease detection by protein profiling
WO2008134526A2 (en) 2007-04-27 2008-11-06 University Of Florida Research Foundation Inc. Glycoprotein profiling of bladder cancer
EP2153234A2 (en) * 2007-05-11 2010-02-17 The Institutes for Pharmaceutical Discovery, LLC Methods for early diagnosis of kidney disease
KR100928403B1 (ko) 2008-10-01 2009-11-26 경북대학교 산학협력단 티지비엠 신증의 진단용 조성물 및 키트
PT2391653E (pt) * 2009-01-28 2015-02-13 Ind Tech Res Inst Biomarcadores associados a nefropatia
KR100930025B1 (ko) * 2009-07-06 2009-12-07 경북대학교 산학협력단 이뮤노글로블린 에이 신증의 진단용 조성물 및 키트
NZ630277A (en) 2009-09-21 2015-02-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102590491B (zh) * 2012-02-06 2014-12-10 中国人民解放军第三军医大学第一附属医院 一种用于早期筛查或辅助诊断泌尿系统疾病的检测试剂盒、检测方法及其用途
WO2013152989A2 (en) 2012-04-10 2013-10-17 Eth Zurich Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer
WO2013162368A1 (en) 2012-04-26 2013-10-31 Stichting Vu-Vumc Biomarkers
US20140038203A1 (en) 2012-07-09 2014-02-06 Musc Foundation For Research Development Methods for detecting or predicting kidney disease
US20140186332A1 (en) * 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
KR101361038B1 (ko) 2013-02-21 2014-02-12 경북대학교 산학협력단 신장 이식 후 환자의 뇨 시료로부터 사구체여과율을 예측하는 방법
JP2016188761A (ja) * 2013-08-23 2016-11-04 国立研究開発法人国立国際医療研究センター 糖尿病腎症の発症または発症リスクの検出方法及びキット
US10078089B2 (en) 2014-08-29 2018-09-18 Children's Hospital Medical Center Compositions and methods for treating steroid resistant nephrotic syndrome and/or steroid sensitive nephrotic syndrome
EP3314027A4 (en) * 2015-06-29 2019-07-03 Caris Science, Inc. THERAPEUTIC OLIGONUCLEOTIDES
PL236671B1 (pl) 2015-12-02 2021-02-08 Inst Biochemii I Biofizyki Polskiej Akademii Nauk Sposób analizy białek w próbce moczu

Also Published As

Publication number Publication date
PL3469372T3 (pl) 2023-12-04
EP3469372B1 (en) 2023-03-08
EP3469372A1 (en) 2019-04-17
US20190339284A1 (en) 2019-11-07
ES2946541T3 (es) 2023-07-20
WO2017212463A1 (en) 2017-12-14
US11029314B2 (en) 2021-06-08

Similar Documents

Publication Publication Date Title
IL276907A (en) Modified stem cell memory t cells, methods of making and methods of using same
EP3639619A4 (en) Apparatus of gnb to enable an inactive mode in dual connectivity
IL254734B1 (en) Modified t cells and methods of making and using the same
DK3099172T3 (da) Modificeret biologisk bekæmpelsesmiddel og anvendelser deraf
DK3702373T3 (da) Anti-PD1-antistoffer og deres anvendelse som terapeutika og diagnostika
BR112016010095A2 (pt) ácidos nucleicos de célula livre para a ánalise de microbioma humano e componentes do mesmos.
BR112016021626A2 (pt) indazol-3-carboxamidas 5-substituídas e preparação e uso das mesmas
PT3092946T (pt) Aparelhos e métodos para determinar tecidos danificados utilizando medições de humidade subepidérmica
BR112016009958A2 (pt) dispositivo microfluídico, método, sistema e kit
DK3540429T3 (da) Indretning og fremgangsmåder til anvendelse af indretning til detektion af hyperammoniæmi
DK2962637T3 (da) Fremgangsmåde og anordning til overvågning af menneskelig bevægelsesstatus
PL3247791T3 (pl) Uniwersalne komórki nkt
DK3327141T3 (da) Fremgangsmåde til identificering af den cellulære sammensætning i en biologisk prøve
HUE050430T2 (hu) Fekális mikrobióta mintavételezési eljárás
BR112017026440A2 (pt) testador de bateria eficiente.
IL247827A0 (en) Cross-flow electrochemical separation devices and methods of assembling same
DK3079719T3 (da) ANTI-SIGLEC-8-antistoffer og fremgangsmåder til anvendelse deraf
DK3319612T3 (da) Oxysteroler og fremgansmåder til anvendelse derfor
DK3332255T3 (da) Vanddispergerbare analyser
EP3951400C0 (en) SAMPLE SELECTOR
DK3131577T3 (da) Modificerede værtsceller og anvendelser deraf
DK3177920T3 (da) På-stedet-diagnosesystem og fremgangsmåde dertil
EP3692914C0 (en) BLOOD SAMPLE MANAGEMENT USING OPEN CELL FOAM
DK3066268T3 (da) Indretning og fremgangsmåde til begrænsning eller konstantholdelse af en strømmende væskemængde
EP3303605C0 (en) MULTI-MEDIATOR REAGENT FORMULATIONS FOR USE IN ELECTROCHEMICAL DETECTION